Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

1.8K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

23.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

3.4K
3.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PCBP1 orchestrates amino acid metabolism burst during the naïve-to-primed pluripotency transition.

Stem cell reports·2026
Same author

Induction of fibrosis in human kidney organoids delineates mechanisms and therapeutic targets of fibrotic kidney disease.

Stem cell research & therapy·2026
Same author

Developmental regulation of Erk signaling by mitotic kinases.

Science advances·2026
Same author

Suboptimal codon pairs trigger ribosome collisions and cellular quality control responses in tRNA modification mutants.

Nucleic acids research·2025
Same author

Dual role of Oct4 and Sox2 in controlling the developmental capacity and timing of tissue morphogenesis in the embryonic lineage.

Developmental cell·2025
Same author

Machine learning and microfluidic integration for oocyte quality prediction.

Scientific reports·2025

Related Experiment Video

Updated: May 6, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

8.7K

Signaling roadmap modulating naive and primed pluripotency.

Seyedeh-Nafiseh Hassani1, Mehdi Totonchi, Hamid Gourabi

  • 11 Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology , ACECR, Tehran, Iran .

Stem Cells and Development
|October 24, 2013
PubMed
Summary

Human and mouse embryonic stem cells (ESCs) represent distinct naive and primed pluripotency states. Understanding signaling pathways is key to inducing stable naive pluripotency in human ESCs.

More Related Videos

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.1K
RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells
11:38

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

11.5K

Related Experiment Videos

Last Updated: May 6, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

8.7K
Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.1K
RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells
11:38

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

11.5K

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Epigenetics

Background:

  • Human embryonic stem cells (hESCs) and mouse ESCs (mESCs) exist in distinct pluripotent states: primed and naive, respectively.
  • Naive pluripotency (mESCs) is characterized by dependence on leukemia inhibitory factor and two active X chromosomes in females.
  • Primed pluripotency (hESCs) resembles mouse epiblast stem cells, requires basic FGF, and shows lineage differentiation bias.

Purpose of the Study:

  • To elucidate the differences between naive and primed pluripotency states in human and mouse embryonic stem cells.
  • To explore the potential for interconversion between these pluripotent states by modifying culture conditions.
  • To identify key pluripotency signaling pathways and their cross-talk for inducing stable naive pluripotency in human cells.

Main Methods:

  • Comparative analysis of hESCs and mESCs.
  • Investigation of culture condition modifications for pluripotency state interconversion.
  • Focus on identifying major pluripotency-related signaling pathways and their networks.

Main Results:

  • Established that mESCs represent naive pluripotency while hESCs represent primed pluripotency.
  • Highlighted that while interconversion is possible, truly naive hESCs have not been unequivocally obtained.
  • Indicated the necessity of understanding signaling pathway functions and cross-talk.

Conclusions:

  • Significant differences exist between naive and primed pluripotency states in human and mouse ESCs.
  • Achieving stable naive pluripotency in human cells requires a deeper understanding of underlying signaling mechanisms.
  • Further research into pluripotency signaling pathways is crucial for therapeutic applications.